Albemarle Corporation
ALB
$191.10
-4.90%
Albemarle Corporation is a global leader in the production of lithium and bromine, operating within the specialty chemicals industry. As a fully integrated lithium producer, the company holds a distinct competitive position with upstream resources including salt brine deposits and hard rock mines, coupled with refining plants across key geographies like Chile, the US, Australia, and China. The current investor narrative is intensely focused on the stock's dramatic recovery from the depths of the lithium price downturn, debating whether the recent price surge reflects a sustainable rebound in lithium demand for electric vehicles or a volatile overshoot, with recent news highlighting the stock as a potential value play amid a 'lithium-fueled rebound'.…
ALB
Albemarle Corporation
$191.10
Related headlines
ALB 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Albemarle Corporation's 12-month outlook, with a consensus price target around $248.43 and implied upside of +30.0% versus the current price.
Average Target
$248.43
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$153 - $248
Analyst target range
Analyst coverage for Albemarle appears limited in the provided dataset, with only 4 analysts cited for earnings estimates. The institutional ratings data shows a mix of actions: recent moves include B of A Securities upgrading from Neutral to Buy in February 2026, while others like Citigroup and Mizuho maintain Neutral stances. This pattern suggests a cautiously optimistic shift among some analysts, likely tied to the belief the lithium cycle has bottomed. The consensus sentiment leans neutral-to-bullish, but the limited number of explicit price targets in the data prevents calculating a precise implied upside or downside to a consensus target. The target range, inferred from earnings estimates, is wide. The high EPS estimate of $16.65 and low of $12.24 for the forecast period imply significant divergence in views on the speed and magnitude of the earnings recovery. The high target likely assumes a sharp rebound in lithium prices and strong volume growth, while the low target prices in a more protracted period of oversupply and margin pressure. The wide spread between analyst actions (Buy, Outperform, Neutral) and the implied earnings range signals high uncertainty and low conviction about the near-term fundamental trajectory, which is typical for a commodity stock at a potential cyclical inflection point.
ALB Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a staggering 1-year price change of +226.84%. As of the latest close at $193.88, the price is trading near the top of its 52-week range, approximately 90% of the way from its low of $53.70 to its high of $215.71, indicating strong momentum but also proximity to a major technical resistance level that could signal overextension. Recent momentum shows a deceleration from the explosive longer-term trend, with a 1-month gain of +8.63% and a 3-month gain of +13.63%, both positive but notably slower than the 6-month surge of +97.37%, suggesting the rally may be entering a consolidation phase as it approaches its all-time high. Key technical support is anchored at the 52-week low of $53.70, though more immediate support has formed in the $160-$170 range during recent pullbacks. The primary resistance is the 52-week high of $215.71; a decisive breakout above this level would signal a resumption of the primary bull trend, while a failure could lead to a deeper correction. The stock's beta of 1.433 indicates it is approximately 43% more volatile than the broader market (SPY), which is critical for risk management given its commodity-driven price swings, as seen in the significant 1-year relative strength of +197.80% versus the SPY.
Beta
1.36
1.36x market volatility
Max Drawdown
-20.1%
Largest decline past year
52-Week Range
$54-$221
Price range past year
Annual Return
+212.9%
Cumulative gain past year
| Period | ALB Return | S&P 500 |
|---|---|---|
| 1m | +0.7% | +7.7% |
| 3m | +14.9% | +9.7% |
| 6m | +66.0% | +11.3% |
| 1y | +212.9% | +27.3% |
| ytd | +32.8% | +9.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ALB Fundamental Analysis
Revenue growth has been volatile but showed a positive trajectory in the most recent quarter, with Q4 2025 revenue of $1.43 billion representing a year-over-year increase of 15.94%. However, examining the quarterly sequence reveals instability: revenue grew from $1.07B in Q1 to a peak of $1.43B in Q4 2025, but this follows a period of significant contraction in late 2024. Segment data indicates the Energy Storage (lithium) division, at $759 million, is the primary revenue driver, significantly outpacing the Ketjen and Specialties segments. The company is currently unprofitable on a net income basis, posting a Q4 2025 net loss of -$414.2 million, which translates to a net margin of -29.0%. Gross margin for the quarter was a thin 14.2%, reflecting ongoing pressure from lithium carbonate prices. The path to profitability is uneven; while the Q4 2025 EBITDA of $212.0 million and operating income of $48.3 million show some operational earnings power, the substantial net loss is driven by large non-operating expenses, including a $292.7 million total other income expense net charge. The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.35, indicating a conservative capital structure. Liquidity is strong with a current ratio of 2.23. Most notably, the company generated substantial trailing twelve-month free cash flow of $692.5 million, providing significant internal funding capacity for growth and debt service. The return on equity is deeply negative at -5.36%, underscoring the current period of earnings distress, but the robust FCF suggests underlying cash generation remains intact despite the accounting losses.
Quarterly Revenue
$1.4B
2025-12
Revenue YoY Growth
+0.15%
YoY Comparison
Gross Margin
+0.14%
Latest Quarter
Free Cash Flow
$692466000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ALB Overvalued?
Given the negative net income and EPS of -$0.03, the primary valuation metric selected is the Price-to-Sales (PS) ratio. Albemarle trades at a trailing PS ratio of 3.24 and an Enterprise Value-to-Sales (EV/Sales) of 5.32. The forward-looking perspective is more relevant, with analyst estimates pointing to revenue of $8.79 billion, which would imply a forward PS ratio materially lower than the current trailing multiple, suggesting the market is pricing in significant revenue growth and a potential margin recovery. Compared to industry averages, the valuation is complex due to the company's unique lithium exposure. The provided data lacks a direct industry average PS ratio, but the stock's own historical PS context is telling. The current PS of 3.24 is near the bottom of its multi-year historical range, which has seen peaks above 30 during the lithium boom of 2021-2022. This suggests the stock is being valued as if in a deep cyclical trough, a stark contrast to the premium multiples commanded during peak lithium pricing. Historically, the stock's valuation has swung wildly with lithium prices. The current PS ratio of 3.24 is dramatically lower than the highs above 30 seen in 2021 and 2022, and is also below levels seen in late 2023 and early 2024 (e.g., 11.66 in Q4 2025). This compression indicates the market has severely de-rated the stock, pricing in a prolonged downturn. Trading near historical valuation lows presents a potential value opportunity if the lithium cycle inflects, but also reflects justified pessimism if weak pricing persists.
PE
-32.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -1788x~1549x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.3x
Enterprise Value Multiple

